Novacyt (FR:ALNOV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Novacyt has launched two new multiplex qPCR tests for detecting gastrointestinal diseases in cats and dogs, debuting at the London Vet Show. These tests streamline the detection of six crucial pathogens, offering faster results and efficiency for veterinary laboratories. This innovation aligns with Novacyt’s commitment to enhancing diagnostic solutions in the veterinary sector.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.